The multivariate evaluation by Logistic analysis demonstrated that invasion depth (P = 0.011), lymph node metastasis (P = 0.043) and TNM stage (P = 0.049) were the independent risk factors for CD133 protein expression respectively (Table 2). The gene discussed is PROM1; the disease is metastatic malignant neoplasm in the lymph nodes.